Hoechst Pakistan Limited (HPL): FY24 Corporate Briefing Takeaways - By Taurus Research

<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">HPL, formerly known as Sanofi-Aventis Pakistan Limited, has experienced a remarkable transformation since its acquisition by Packages Group. The Company has seen significant growth, reflected in its recent financial performance, including its highest-ever PAT. In FY24, HPL reported a revenue of ~PKR 26Bn, marking a 25%YoY increase from PKR 21Bn in FY23.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">The Company's margins improved by 6ppts, reaching 32%, driven by a favorable sales mix and a robust product portfolio. Notably, HPL achieved a PAT of ~PKR 1.8Bn, up 4.2xYoY from PKR 361Mn in the previous year. This impressive growth can be attributed to higher sales, enhanced gross margins, effective cos...